EADV 2026: Placebo Response in Hidradenitis Suppurativa Trials
Placebo responses can complicate the interpretation of clinical trials investigating immunomodulatory treatments for hidradenitis suppurativa (HS). In this MEDtalk, Nina Qiu, Medical Student, Bispebjerg Hospital, Copenhagen, Denmark, presents a systematic review and meta-analysis of 39 randomized controlled trials, exploring the magnitude of placebo responses, factors associated with them, and their implications for future trial design.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in






